NextCell Pharma (Sweden) Analysis
| NXTCL Stock | SEK 2.40 0.04 1.69% |
NextCell Pharma AB is overvalued with Real Value of 1.99 and Hype Value of 2.4. The main objective of NextCell Pharma stock analysis is to determine its intrinsic value, which is an estimate of what NextCell Pharma AB is worth, separate from its market price. There are two main types of NextCell Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect NextCell Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of NextCell Pharma's stock to identify patterns and trends that may indicate its future price movements.
The NextCell Pharma stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. NextCell Pharma is usually not traded on All Saints ' Day, St . John 's Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay. NextCell Stock trading window is adjusted to Europe/Stockholm timezone.
NextCell |
NextCell Stock Analysis Notes
About 43.0% of the company outstanding shares are owned by corporate insiders. The book value of NextCell Pharma was now reported as 3.1. The company recorded a loss per share of 0.81. NextCell Pharma AB had not issued any dividends in recent years. NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. NextCell Pharma AB was founded in 2014 and is based in Huddinge, Sweden. NextCell Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 10 people. To find out more about NextCell Pharma AB contact Mathias Svahn at 46 87 35 55 95 or learn more at https://www.nextcellpharma.com.NextCell Pharma AB Investment Alerts
| NextCell Pharma AB is way too risky over 90 days horizon | |
| NextCell Pharma AB appears to be risky and price may revert if volatility continues | |
| NextCell Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.59 M. Net Loss for the year was (35.02 M) with loss before overhead, payroll, taxes, and interest of (2.49 M). | |
| NextCell Pharma AB has accumulated about 150.75 M in cash with (33.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company outstanding shares are owned by corporate insiders |
NextCell Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 255.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NextCell Pharma's market, we take the total number of its shares issued and multiply it by NextCell Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 19th of January, NextCell Pharma secures the Risk Adjusted Performance of 0.0603, downside deviation of 4.69, and Mean Deviation of 3.74. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NextCell Pharma AB, as well as the relationship between them. Please verify NextCell Pharma AB coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if NextCell Pharma AB is priced some-what accurately, providing market reflects its recent price of 2.4 per share.NextCell Pharma AB Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NextCell Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NextCell Pharma AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NextCell Pharma Outstanding Bonds
NextCell Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NextCell Pharma AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NextCell bonds can be classified according to their maturity, which is the date when NextCell Pharma AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
NextCell Pharma Predictive Daily Indicators
NextCell Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NextCell Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NextCell Pharma Forecast Models
NextCell Pharma's time-series forecasting models are one of many NextCell Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NextCell Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NextCell Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NextCell Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NextCell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NextCell Pharma. By using and applying NextCell Stock analysis, traders can create a robust methodology for identifying NextCell entry and exit points for their positions.
NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. NextCell Pharma AB was founded in 2014 and is based in Huddinge, Sweden. NextCell Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 10 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NextCell Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.